Democratizing hedge fund level analysis tools for everyone
| Name | Ikapharmindo Putramas Tbk. |
| Sector | Healthcare |
| Industry | Pharmaceuticals & Health Care Research |
| Code | F2 |
| Latest Quarterly | 06-30-25 |
| Name | Latest % | A Month Ago % |
|---|---|---|
| PT. Ikapharma Inti Mas | 78.12 | 78.12 |
| Public < 5% | 20.19 | 20.19 |
| Dra. Maudy Ratna Winata | 0.88 | 0.88 |
| Drs. Titianus Winata | 0.62 | 0.62 |
| Augustina Winata | 0.19 | 0.19 |
| Eliza Arlena Winata | 0.19 | 0.19 |
| Source | 2022 | 2021 |
|---|
| Region | 2022 | 2021 |
|---|
| Valuation | Ratio | Rank |
|---|---|---|
| P/S | 1.04 | # 8 / 15 |
| EV_EBITDA | -24.90 | --- / 15 |
| PER | -8.46 | --- / 15 |
| PBV | 1.73 | # 8 / 15 |
| DER | 1.10 | # 8 / 15 |
| Profitability | Ratio | Rank |
|---|---|---|
| NPM % | -12.43 | --- / 15 |
| ROA % | -9.47 | --- / 15 |
| ROE % | -20.669999999999998 | --- / 15 |
| Year | DPS | Yield [%] |
|---|---|---|
| 2024 | 4.5 | 1.8 |
| Timeframe | Performance |
|---|---|
| 1W % | -1.9 |
| 1Mo % | -11.7 |
| 3Mo % | -3.6 |
| 1Yr % | -17.8 |
| Stocks | PER | Market Cap | EV | Revenue | EBITDA | Net Profit |
|---|---|---|---|---|---|---|
| KLBF | 16.21 | 56.88 T | 58.14 T | 34,651 B | 5,348 B | 3,508 B |
| SOHO | 30.18 | 17.51 T | 19.64 T | 10,338 B | 711 B | 581 B |
| SIDO | 14.84 | 16.20 T | 15.77 T | 3,639 B | 1,481 B | 1,091 B |
| TSPC | 8.20 | 12.45 T | 10.93 T | 13,512 B | 2,016 B | 1,515 B |
| PYFA | -11.02 | 5.39 T | 11.42 T | 2,747 B | -142 B | -488 B |
| MDLA | 9.50 | 3.67 T | 6.27 T | 14,788 B | 557 B | 386 B |